title: Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab.
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC; Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC. Electronic address: caitlin_burk@med.unc.edu.
authors.forename: Caitlin M
authors.initials: CM
authors.lastname: Burk
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC; Division of Gastroenterology and Hepatology, Department of Medicine, Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Evan S
authors.initials: ES
authors.lastname: Dellon
authors.affiliation: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Pamela H
authors.initials: PH
authors.lastname: Steele
authors.affiliation: Department of Pediatrics, Massachusetts General Hospital, Boston, Mass.
authors.forename: Yamini V
authors.initials: YV
authors.lastname: Virkud
authors.affiliation: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Mike
authors.initials: M
authors.lastname: Kulis
authors.affiliation: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
authors.affiliation: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Brian P
authors.initials: BP
authors.lastname: Vickery
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000485:Allergens / Q000276:immunology; D010367:Arachis / Q000276:immunology; D002648:Child; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis*; D057765:Eosinophilic Esophagitis / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007167:Immunotherapy / Q000009:adverse effects / Q000379:methods*; D008297:Male; D000069444:Omalizumab / Q000009:adverse effects / Q000627:therapeutic use*; D021183:Peanut Hypersensitivity / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000485:Allergens; D000069444:Omalizumab; D007073:Immunoglobulin E